| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 9.36B | 5.42B | 4.63B | -4.04B | 4.69B |
| Gross Profit | 9.26B | 5.37B | 1.26B | -4.15B | 4.56B |
| EBITDA | 371.00M | 108.00M | 163.00M | 144.00M | 160.00M |
| Net Income | 120.00M | -34.00M | 42.00M | 175.00M | 154.00M |
Balance Sheet | |||||
| Total Assets | 76.54B | 62.45B | 53.34B | 46.42B | 50.74B |
| Cash, Cash Equivalents and Short-Term Investments | 2.15B | 60.94B | 51.86B | 45.13B | 49.34B |
| Total Debt | 271.00M | 275.00M | 279.00M | 290.00M | 299.00M |
| Total Liabilities | 75.08B | 61.02B | 51.83B | 44.87B | 49.00B |
| Stockholders Equity | 1.47B | 1.42B | 1.52B | 1.55B | 1.74B |
Cash Flow | |||||
| Free Cash Flow | 6.16B | 4.58B | 2.11B | 1.67B | 3.06B |
| Operating Cash Flow | 6.17B | 4.58B | 2.11B | 1.67B | 3.07B |
| Investing Cash Flow | -5.86B | -4.41B | -1.91B | -1.51B | -2.63B |
| Financing Cash Flow | -106.00M | -108.00M | -123.00M | -452.00M | -298.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £8.91B | 11.95 | 12.35% | 5.37% | 4.78% | -4.86% | |
74 Outperform | £2.34B | 20.62 | 8.35% | 3.40% | -28.04% | -102.43% | |
72 Outperform | £207.67M | 13.32 | 7.58% | 5.14% | -13.29% | 63.87% | |
72 Outperform | £1.01B | 22.35 | 23.86% | 3.11% | 7.13% | -1.52% | |
70 Outperform | £2.05B | 17.89 | 4.75% | 4.91% | 14.05% | -3.07% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | £1.86B | 21.09 | 49.89% | 2.43% | 17.97% | 25.51% |